Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(50.0%)
N/A
1(25.0%)
Phase 3
1(25.0%)
4Total
Phase 4(2)
N/A(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03745677Not ApplicableCompleted

Redesigning Systems to Improve Quality for Hospitalized Patients

Role: collaborator

NCT04086186Phase 4Completed

Adductor Canal Block Versus Liposomal Bupivacaine in TKA

Role: lead

NCT02580227Phase 4Unknown

Tranexamic Acid in Intertrochanteric and Subtrochanteric Femur Fractures

Role: lead

NCT01107574Phase 3Completed

Fibromyalgia Treatment Trial With Gabapentin and Osteopathic Manipulative Medicine

Role: lead

All 4 trials loaded